Acute piperacillin+tazobactam shortage – important advice – JHH and HNELHD

October 17, 2017 · by · in AMS strategy, Hospital practice · 2 Comments

Currently (still in Feb 2018) there is a worldwide shortage of piperacillin+tazobactam , an additional issue to the shortage earlier in 2017 .

Appropriate substitutions – see – HNELHD advice (November 2017)  JHH_Pip_Taz_Fact_Sheet_Oct_2017 . This includes new dosage recommendations for IV amox+clavulanate for intra-abdominal infection (6 -hrly rather than 8- hrly dosing).

For further advice, please contact the Hunter New England Local Health District Infectious Diseases or Microbiology Services via 02 49213000.

Tags:

2 comments

  1. rphmanzoor · · Reply→

    Tazocin is the combination of tazobactum and piperacillin and is used in the treatment of Hospital accquired pneumonia,complicated intra abdominal infection, septicaemia (Blood Poisoning),
    Complicated infection involving urinary tract infections and skin and soft tissue infections.
    It is also used in infections in neutropenic patients (Low white Blood Count)
    More here
    http://www.drugsbanks.com/2017/12/08/tazocin-piperacillin-tazobactam/

    Like

  2. ACIPC presentation – VRE control update Nov 2021 | AIMED - Let's talk about antibiotics · · Reply→

    […] https://aimed.net.au/2017/10/17/acute-piperacillintazobactam-shortage-important-advice-jhh-and-hnelh… […]

    Like

Leave a Reply

Fill in your details below or click an icon to log in:

Gravatar
WordPress.com Logo

You are commenting using your WordPress.com account. ( Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. ( Log Out /  Change )

Cancel

Connecting to %s

%d bloggers like this: